Natera is seeking an experienced Clinical Director, Oncology Clinical Development to provide medical and scientific leadership for Natera-sponsored oncology clinical trials focused on minimal residual disease (MRD). In this pivotal role, you’ll drive the design and execution of biomarker-driven interventional and randomized studies that integrate MRD testing into precision oncology strategies to support regulatory, scientific, and strategic objectives.
We’re looking for an innovative clinical leader with deep oncology clinical development experience who thrives in a fast-paced, collaborative environment — and who’s passionate about transforming cancer care.
Natera’s MRD platform is redefining precision oncology—enabling earlier detection, improved monitoring, and smarter treatment decisions. In this role, you’ll lead studies that directly shape how cancer is managed worldwide, bringing actionable insights to clinicians and patients when they matter most.
Clinical & Program Leadership
Serve as the program-level medical lead for Natera-sponsored MRD clinical trials across assigned oncology indications, with ultimate accountability for clinical outcomes, data integrity, and patient safety.
Define clinical development strategies that align study design, endpoints, and execution with regulatory and scientific objectives.
Provide medical oversight across the full trial lifecycle, from design and protocol development through first patient in (FPI), data readout, and study close-out.
Study Design & Execution
Provide strategic and medical guidance to Clinical Scientists, fostering collaboration on protocol design, data interpretation, and translational insights that drive clinical program success.